Share Capital (Tables)

12 Months Ended

Mar. 31, 2018

Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Abstract]

An unlimited number of common shares.

(i)

Equity Raises

During fiscal 2018 the Company completed the following equity financings:

	Number of Shares		Share Capital
Equity financing - February 7, 2018 - net of share issue costs of $8,615		5,800,000	$	192,065
Equity investment from Greenstar - November 2, 2017 - net of share issue costs of $707		18,876,901		173,765
Equity financing - July 21, 2017 - net of share issue costs of $78		3,105,590		24,922
Total equity raise share issuances		27,782,491	$	390,752

20.	Share capital (CONTINUED)

During fiscal 2017 the Company completed the following equity financings:

	Number of Shares		Share Capital
Equity private placement financing - March 22, 2017 - net of share issue costs of $90		2,500,000	$	24,160
Equity financing - December 22, 2016 - net of share issue costs of $3,886		5,662,000		56,131
Equity financing - August 24, 2016 - net of share issue costs of $2,407		9,453,000		32,096
Equity financing - April 15, 2016 - net of share issue costs of $707		5,002,500		10,799
Total equity raise share issuances		22,617,500	$	123,186

Summary of Equity Issuances Related to Acquisitions

	Notes	Number of Shares		Share Capital		Share Based Reserve
Issuance of shares for rTrees acquisition - net of share issue costs of $69	10(a)(i)		3,494,505	$	28,026	$	1,079
Issuance of shares for Spot acquisition - net of share issue costs of $9	10(a)(v)		111,669		984		-
Issuance of shares for Green Hemp acquisition - net of share issue costs of $9	10(a)(v)		24,577		848		-
Shares released from escrow related to the MedCann Access acquisition			240,678		390		(390	)
Shares released from escrow related to the Hemp.CA acquisition	10(b)(iii)		129,016		-		-
Shares released from escrow related to the Spektrum Cannabis GmbH acquisition	10(b)(ii)		367,981		-		-
Shares released from escrow related to the Vert Medical acquisition	10(b)(iii)		147,453		-		-
Total acquisition related share issuances			4,515,879	$	30,248	$	689

20.	Share capital (CONTINUED)

During fiscal 2017 the Company issued the following shares as a result of business combinations that occurred in the current or prior years:

	Notes	Number of Shares		Share Capital		Share Based Reserve
Issuance of shares for Mettrum acquisition - net of share issue costs of $997	10(b)(i)		34,265,042	$	336,514	$	12,143
Issuance of shares per Spektrum Cannabis GmbH acquisition	10(b)(ii)		674,631		10,406		-
Issuance of shares per Vert acquisition	10(b)(iii)		58,978		1,664		-
Issuance of shares per Hemp acquisition	10(b)(iii)		129,021		1,711		-
Shares released from escrow related to the MedCann Access acquisition			1,011,239		2,919		(468	)
Total acquisition related share issuances			36,138,911	$	353,214	$	11,675

Summary of Other Equity Issuances

During fiscal 2018 the Company other share issuances were comprised of:

	Notes	Number of Shares		Share Capital		Share Based Reserve
Shares released from escrow to LBC Holdings, Inc.			87,836	$	1,297	$	(1,297	)
Shares issued to BC Tweed Partner for performance conditions	20(c)		155,158		1,880		(1,880	)
Shares issued for Apollo/Bodystream earnout	20(c)		243,493		2,398		(2,398	)
Issuance of shares for Niagara asset acquisition - net of share issue costs of $8	9		111,366		995		-
Issuance of shares for acquired intangible - net of share issue costs of $14	11		117,253		3,225		-
Total other share issuances			715,106	$	9,795	$	(5,575	)

During fiscal 2017 the Company other share issuances were comprised of:

		Number of Shares		Share Capital		Share Based Reserve
Shares released from escrow to LBC Holdings, Inc.			138,032	$	639	$	(639	)
Issuance of shares for 1 Hershey Drive purchase	9		94,397		858		-
Issuance of shares per service agreements			156,240		1,333		-
Total other share issuances			388,669	$	2,830	$	(639	)

Summary of Warrants

(i)

Warrants

	Number of whole warrants			Average exercise price		Warrant value			Expiry date
Balance at March 31, 2017		-		$	-	$	-
Greenstar equity investment - net of warrant issue cost of $253		18,876,901			12.98		70,265		May 1, 2020
rTrees acquisition		242,408			3.83		1,302		April 30, 2018
Exercise of warrants		(207,297	)		3.72		(1,113	)	N/A
Balance at March 31, 2018		18,912,012		$	12.96	$	70,454

Summary of Changes in ESOP Options

20.	Share capital (CONTINUED)

The following is a summary of the changes in the Company’s ESOP options during the period:

	Options issued			Weighted average exercise price
Balance outstanding at March 31, 2016		8,446,182		$	2.05
Options granted		4,337,701			6.23
Replacement options issued as a result of the Mettrum acquisition		2,417,102			2.35
Options exercised		(4,010,865	)		1.74
Options forfeited/cancelled		(1,146,008	)		2.78
Balance outstanding at March 31, 2017		10,044,112		$	3.97
Options granted		12,832,237			16.50
Replacement options issued as a result of the rTrees acquisition		224,433			3.18
Options exercised		(3,912,946	)		2.82
Options forfeited/cancelled		(1,942,001	)		9.32
Balance outstanding at March 31, 2018		17,245,835		$	12.95

Summary of Outstanding Stock Options

The following is a summary of the outstanding stock options as at March 31, 2018:

Options Outstanding					Options Exercisable
Number Outstanding at March 31, 2018		Weighted Average Remaining Contractual Life (years)		Range of Exercise Prices	Number Exercisable at March 31, 2018		Range of Exercise Prices

	3,471,904		3.41	$0.56 - $3.78		1,569,274	$0.56 - $3.78
	5,731,691		5.13	$3.79 - $8.51		577,665	$3.79 - $8.51
	2,712,240		4.91	$8.52 - $11.76		536,254	$8.52 - $11.76
	1,540,000		5.67	$11.77 - $27.94		16,667	$11.77 - $27.94
	3,790,000		5.88	$27.95 - $33.66		-	$27.95 - $33.66

	17,245,835		4.96			2,699,860

Summary of Assumptions Used Following Black-Scholes Option Pricing Model to Establish Fair Value of Options

20.	Share capital (CONTINUED)

In determining the amount of share-based compensation related to options issued during the year, the Company used the Black-Scholes option pricing model to establish the fair value of options granted during the year ended March 31, 2018 and 2017 on their measurement date by applying the following assumptions:

	March 31,		March 31,
	2018		2017
	(Weighted average)		(Range)
Risk-free interest rate	1.54%		0.50% - 1.94%
Expected life of options (years)	3 - 5		1 - 6
Expected annualized volatility	64%		55% - 70%
Expected forfeiture rate	11%		7%
Expected dividend yield	nil		nil
Black-Scholes value of each option	$	8.88	$0.20 - $6.09

Summary of Share-based Compensation Expense related to Acquisition

Share-based compensation expense related to acquisition milestones is comprised of:

						Compensation expense
	Notes	Released during fiscal 2018		Remaining shares to be issued on completion of milestones*		March 31, 2018		March 31, 2017
Apollo/Bodystream	(i)		243,493		1,941,804	$	5,095	$	690
Spektrum Cannabis GmBH	(ii)		-		23,570		349		-
Spot	10(a)(v)		-		30,658		330		-
Spectrum Denmark	10(a)(iii)		-		1,906,214		7,206		-
BC Tweed	13		155,158		240,061		5,001		-
Vert Mirabel	10(a)(iv)		-		84,903		1,131		-
Green Hemp	10(a)(v)		-		24,567		167		-
Intellectual property acquisition	11		-		33,804		196		-
						$	19,475	$	690

20.	Share capital (CONTINUED)

(i)

The obligation for share-based compensation owing to former shareholders of Apollo Applied Research Inc., and Apollo CRO Inc. (together “Apollo”) and 2344823 Ontario Inc., operating as Bodystream (“Bodystream”) was assumed by the Company in fiscal 2017 on the acquisition of Mettrum Health Corp. and its subsidiaries (“Mettrum”). The maximum number of Company shares that would be issued with respect to the Apollo and Bodystream agreements is 1,111,702 and 1,073,595 shares, respectively. The Company has estimated the number of shares it expects to vest and is amortizing the expense over the expected vesting period based on the fair value of the shares on the acquisition date.

(ii)

The share-based compensation expense is related to a bonus that will be paid to a former shareholder of Spektrum Cannabis GmbH within two years of the acquisition date if certain performance targets are met and the shareholder remains as an employee.